Consider Cardioselective beta-blockers for people with asthm
Cardiovascular disease (CVD) is a common comorbidity in people with asthma. However, safety concerns have caused heterogeneity in clinical guideline recommendations over the use of cardioselective beta-blockers in people with asthma and CVD, partly because risk in the general population has been poorly quantified. The aim of this study was to measure the risk of asthma exacerbations with beta-blockers prescribed to a general population with asthma and CVD.

http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0781-0
Like
Comment
Share